Antimicrobial susceptibility testing market

Antimicrobial Susceptibility Testing Market, by Product Type (Manual Antimicrobial Susceptibility Testing Products (Susceptibility Testing Disks, Mic Strips and Susceptibility Plates), Automated Laboratory Instruments and Consumables), by Application (Antibacterial, Antifungal, Anti-parasitic, and Antiviral), by Method (Disk Diffusion, Rapid Automated AST, Broth Dilution, Gradient Diffusion, and Genotypic Methods) by Distribution Channel (Hospitals, Pathology/Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Jun 2022
CMI2449
258 Pages
Excel & Pdf
Clinical Diagnostic

Summary

Increasing number of pathogenic bacteria are acquiring antibiotic resistance and new forms of resistance are continuously emerging, which enable clinicians to perform antimicrobial susceptibility testing (AST) on priority. A rapid multiplexed AST platform provides minimum inhibitory concentrations (MICs) within hours at reasonable cost, which enables rapid determination of effective targeted therapy, resulting in short hospital stays, few laboratory tests, and decreasing morbidity and mortality along with associated healthcare expenses.

Increasing launches of tests is expected to drive the market growth during the forecast period

For Instance, in 2019, F. Hoffmann-La Roche Ltd., a research-based healthcare company announced the CE-IVD launch of the cobas MTB-RIF/INH test to detect resistance to antibiotics within tuberculosis DNA.

Moreover, in 2018, Beckman Coulter Inc., a subsidiary of Danaher, announced the commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing for microbiology laboratories.

Furthermore, antimicrobial susceptibility testing (AST) aims to ensure that suitable antibiotics are prescribed to infected individuals and also helps to identify resistance isolates with defined resistance mechanisms to infection prevention and control, thereby driving growth of the antimicrobial susceptibility testing market.

The global antimicrobial susceptibility testing market is estimated to be valued at US$ 3,525.75 million in 2022 and expected to exhibit a CAGR of 6.4% over the forecast period (2022-2030).

Figure 1. Global Antimicrobial Susceptibility Testing Market Share (%) in Terms of Value, by Region, 2022

Increasing awareness initiatives by governments for antimicrobial resistance and its control is expected to aid in the growth of the global antimicrobial susceptibility testing market.

Increasing awareness initiatives by governments for antimicrobial resistance and its control is expected to act as an opportunity for the global antimicrobial susceptibility testing market growth

For instance, the Global Sepsis Alliance, located in the U.S., is a non-profit charity organization with the mission to provide global leadership to reduce the worldwide burden of sepsis. It was founded in 2010 with the aim to raise awareness for sepsis worldwide. More than 100 organizations from all over the world have joined the Global Sepsis Alliance. Sepsis is a potentially life-threatening condition that occurs when the body's response to an infection damages its own tissues.

Antimicrobial Susceptibility Testing Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 3,525.75 Mn
Historical Data for:	2017 to 2021	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	6.4%	2030 Value Projection:	US$ 5,808.92 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Manual Antimicrobial Susceptibility Testing Products (Susceptibility Testing Disks, Mic Strips, usceptibility Plates), Automated Laboratory Instruments, Consumable By Application: Antibacterial, Antifungal, Anti-parasitic, Antiviral By Method: Disk Diffusion, Rapid Automated AST, Broth Dilution, Gradient Diffusion, Genotypic Methods By End User: Hospitals, Pathology/Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations
Companies covered:	Thermo Fisher Scientific Inc. and BIOMÉRIEUX, HiMedia Laboratories, Alifax S.r.l. Italy, Creative Diagnostics, Resistell AG, Danaher, Becton, Dickinson and Company, Merck KGaA, Bio-Rad Laboratories, Inc., Bruker, Nissui Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd.,Synbiosis, Mast Group Ltd., ELITechGroup, Flinn Scientific, CONDALAB, Accelerate Diagnostics, Inc. and Zhuhai DL Biotech Co., Ltd.
Growth Drivers:	Rising incidence of infectious diseases Emergence of multidrug resistance worldwide
Restraints & Challenges:	High cost of automated and other antimicrobial susceptibility testing systems

Figure 2. Global Antimicrobial Susceptibility Testing Market Share (%), by Product Type, 2022

Global Antimicrobial Susceptibility Testing Market: Restraint

Automated antimicrobial susceptibility testing systems are equipped with highly advanced features and have high prices.The automated antimicrobial susceptibility testing systems have several advantages such as reduced detection time, accuracy of testing, and others; however, the high price of such systems may act as a restraint for the global antimicrobial susceptibility testing market growth.

For instance, according to an article published by the National Center for Biotechnology Information, a series of databases relevant to biotechnology and biomedicine, in July 2020, the high price of molecular testing for antimicrobial susceptibility forms an efficient barrier for the installation of new technologies. According to the same source, testing costs also include those associated with clinical sampling and cultivation in microbiology labs, the processes that are carried out before antimicrobial susceptibility testing (AST). The roughly estimated total cost for mass spectrometry-based AST is € 79 (US$ 83.3) per patient, when the cost of the MALDI-TOF device, reagents, pharmacist time, and the antimicrobial stewardship program are pooled together.

Key Players

Major players operating in the global antimicrobial susceptibility testing market include Thermo Fisher Scientific Inc. and BIOMÉRIEUX, HiMedia Laboratories, Alifax S.r.l. Italy, Creative Diagnostics, Resistell AG, Danaher, Becton, Dickinson and Company, Merck KGaA, Bio-Rad Laboratories, Inc., Bruker, Nissui Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd.,Synbiosis, Mast Group Ltd., ELITechGroup, Flinn Scientific, CONDALAB, Accelerate Diagnostics, Inc., and Zhuhai DL Biotech Co., Ltd.

Table of Content

Table of Contents

*Browse 45 market data tables and 44 figures on "Global Antimicrobial Susceptibility Testing Market” - forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global antimicrobial susceptibility testing market during the forecast period (2022-2030)?

The global antimicrobial susceptibility testing market size is estimated to be valued at US$ 3,525.75 million in 2022 and expected to exhibit a CAGR of 6.4% between 2022 and 2030.

What are the major factors driving the market growth?

Rising incidence of infectious diseases and emergence of multidrug resistance worldwide is expected to drive the market growth over the forecast period.

Which is the leading product type in the market?

Consumables is expected to hold the major market share in the market.

Which region holds the largest market share in the market?

North America holds the largest market share in the market.

What are the key factors hampering the growth of the market?

Major factors hampering the antimicrobial susceptibility testing market growth include high cost of automated and other antimicrobial susceptibility testing systems.

Which are the major players operating in the market?

Major players operating in the market include Thermo Fisher Scientific Inc. and BIOMÉRIEUX, HiMedia Laboratories, Alifax S.r.l. Italy, Creative Diagnostics, Resistell AG, Danaher, Becton, Dickinson and Company, Merck KGaA, Bio-Rad Laboratories, Inc., Bruker, Nissui Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd.,Synbiosis, Mast Group Ltd., ELITechGroup, Flinn Scientific, CONDALAB, Accelerate Diagnostics, Inc., and Zhuhai DL Biotech Co., Ltd..